Professor and Division Head, Hematology and Medical Oncology, co-Deputy Director, Knight Cancer Insitute
Oregon Health and Science University
Dr. Shivaani Kummar is Associate CEO, Knight Cancer Institute, Margaret and Lester DeArmond Chair of Molecular Oncology, Division Chief of Hematology and Medical Oncology, co-Director of the Center of Experimental Therapeutics, Oregon Health & Science University (OHSU), Portland, Oregon, USA. She specializes in conducting pharmacokinetic and pharmacodynamic driven first-in-human trials tailored to make early, informed decisions regarding the suitability of novel molecular agents for further clinical investigation. She is a member of scientific planning committees of national and international professional organizations and has authored over 180 peer reviewed publications, 9 book chapters, and co-edited a book on ‘Novel Designs of Early Phase Trials for Cancer Therapies’. She is also the PI for an NCI T32 grant to train MDs and PhDs in anticancer drug development.